Christer Ahlberg
Chief Executive Officer at DunMedic AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Myles Murray | M | 38 | 13 years | |
| Anne Dorney | F | 66 | 11 years | |
| Michael Ryan | M | 67 |
Sedana Medical Ltd.
 Sedana Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Sedana Medical Ltd. is an Irish private company located in Kildare. The firm develops anesthetic delivery systems and medical devices. Michael Ryan is currently the CEO of the company. | 15 years |
| Stig Lennart Hansson | M | 68 |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Peter Donnelly | M | 59 | 10 years | |
| Jessica Westfal | F | 50 | 4 years | |
| Eva Walde | F | 61 | 6 years | |
| Ron Farrell | M | 68 |
Sedana Medical Ltd.
Sedana Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Sedana Medical Ltd. is an Irish private company located in Kildare. The firm develops anesthetic delivery systems and medical devices. Michael Ryan is currently the CEO of the company. | - |
| Christoffer Rosenblad | M | 49 | 4 years | |
| Claus Bjerre | M | 53 | 3 years | |
| Ola Gunnar Magnusson | M | 76 |
Sedana Medical Incentive AB
 Sedana Medical Incentive AB Real Estate DevelopmentFinance Sedana Medical Incentive AB provides real estate services. | - |
| Jenni Björnulfson | F | 53 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Peter Sackey | M | 53 | 6 years | |
| Lars Åke Gunnar Hallman | M | 82 |
Unimedic AB
 Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | 10 years |
| Magnus Christensen | M | 50 | 5 years | |
| Sylvia Buddenbaum Eriksson | F | 56 | 4 years | |
| Peter Fröberg | M | 53 | 4 years | |
| Stefan Krisch | M | 50 | 3 years | |
| Torbjörn Mattias Koivisto | M | 55 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | 6 years |
| Tom Meagher | M | 57 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sten Gibeck | M | 81 | 16 years | |
| Jens Lindberg | M | 53 | 2 years | |
| Susanne Andersson | F | 53 | 1 years | |
| Maria Engström | F | 52 | 4 years | |
| Gunilla Mickelsson | F | 53 | - | |
| Stina Sandberg | F | 50 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 21 | 77.78% |
| Ireland | 2 | 7.41% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christer Ahlberg
- Personal Network
